[1] |
Kobayashi S, Sasaki M, Goto T, et al. Endometrioid adenocarcinoma arising from endometriosis of the rectosigmoid [J]. Dig Endos, 2010, 22(1):59-63.
|
[2] |
Katsikogiannis N, Tsaroucha A, Dimakis K, et al. Rectal endometriosis causing colonic obstruction and concurrent endometriosis of the appendix: a case report [J]. J Med Case Rep, 2011, 5:320.
|
[3] |
Pisanu A, Deplano D, Angioni S, et al. Rectal perforation from endometriosis in pregnancy: case report and literature review [J]. World J Gastroenterol, 2010, 16(5):648-651.
|
[4] |
LaGrenade A, Silverberg SG. Ovarian tumors associated with atypical endometriosis [J]. Hum Pathol, 1988, 19(9):1080-1084.
|
[5] |
Ogawa S, Kaku T, Amada S, et al. Ovarian endometriosis associated with ovarian carcinoma: a cliniclpathological and immunohistochemical study [J]. Gynecol Oncol, 2000, 77(2):298-304.
|
[6] |
Czernobilsky B, Morris WJ. A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes [J]. Obstet Gynecol, 1979, 53(3):318-323.
|
[7] |
Fukunaga M, Nomura K, Ishikawa E, et al. Ovarian atypical endometriosis: its close association with malignant epithelial tumours [J]. Histopathology, 1997, 30(3):249-255.
|
[8] |
Worley MJ, Welch WR, Berkowitzwitz RS, et al. Endometriosis-associated ovarian cancer: a review of pathogenesis [J]. Int J Mol Sci, 2013, 14(3):5367-5379.
|
[9] |
Zanetta GM, Webb MJ, Li H, et al. Hyperestrogenenism: a relevant risk factor for the development of cancer from endometriosis [J]. Gynecol Oncol, 2000, 79(1):18-22.
|
[10] |
Kobayashi H, Yamada Y, Kanayama S, et al. The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary [J]. Int J Gynecol Cancer, 2009, 19(3):471-479.
|
[11] |
Keita M, AinMelk Y, Pelmus M, et al. Endometrioid ovarian cancer and endometriotic cells exhibit the same alteration in the expression of interleukin-1 receptor Ⅱ: to a link between endometriosis and endometrioid ovarian cancer [J]. J Obstet Gynaecol Res, 2011, 37(2):99-107.
|
[12] |
Keita M, Bessette P, Pelmus M, et al. Expression of interleukin-1(IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes [J]. J Ovarian Res, 2010,3:3.
|
[13] |
Yamaguchi K, Mandai M, Toyokuni S, et al. Contents of endometriotic cysts, especiallythe high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress [J]. Clin Cancer Res, 2008, 14(1):32-40.
|
[14] |
Matsumoto T,Yamazaki M,Takahashi H,et al.Distinct betacaterin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinoma [J]. Am J Clin Patrol, 2015, 144(3):452-463.
|
[15] |
Gadducci A, Lanfredini N, Tana R.Novel insights on the malignant transformation of endomatriosis into ovarian carcinoma [J]. Gynecol Endocrinol, 2014, 30(9):612-617.
|
[16] |
Anglesio MS, Bashashati A, Wang YK, et al. Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden [J]. J Pathol, 2015, 236(2):201-209.
|
[17] |
Nezhat F, Datta MS, Hanson V, et al. The relationship of endometriosis and ovarian malignancy: a review [J]. Fertil Steril, 2008, 90(5):1559-1570.
|
[18] |
Munksgaard PS, Blaakaer J. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations [J]. Gynecol Oncol, 2012, 124(1):164-169.
|
[19] |
Lai CR, Hsu CY, Chen YJ, et al. Ovarian cancers arising from endometriosis: a microenvironmental biomarker study including ER, HNF1ss, p53, PTEN, BAF250a, and COX-2 [J]. J Chin Med Assoc, 2013, 76(11):629-634.
|
[20] |
McConechy MK, Ding J, Senz J, et al. Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles [J]. Mod Pathol, 2014, 27(1):128-134.
|
[21] |
Kobayashi S, Sasaki M, Goto T, et al. Endometrioid adenocarcinoma arising from endometriosis of the rectosigmoid [J]. Dig Endos, 2010, 22(1):59-63.
|
[22] |
Marchena-Gomez J, Conde-Martel A, Hemmersbach-Miller M, et al. Metachronic malignant transformation of small bowel and rectal endo-metriosis in the same patient [J]. World J Surg Oncol, 2006, 4:93.
|
[23] |
Debus G, Schuhmacher I. Endometrial adenocarcinoma arising during estrogenic treatment 17 years after total abdominal hysterectomy and bilateral salpingo-oophorectomy: A case report [J]. Acta Obstet Gynecol Scand, 2001, 80(6):589-590.
|
[24] |
Ulrich U, Rhiem K, Kaminski M, et al. Paramatrial and rectovaginal adenocarcinoma arising from endometriosis [J]. Int J Gynecol Cancer, 2005, 15(6):1206-1209.
|
[25] |
Remorgida V, Ferrero S, Fulcheri E, et al. Bowel endometriosis:presentation,diagnosis,and treatment [J]. Obstet Gynecol Furv, 2007, 62(7):461-470.
|
[26] |
Cottreau CM, Ness RB, Modugno F, et al. Endometriosis and its treatment with Danazol or Lupron in relation to ovarian cancer [J]. Clinical Cancer Research, 2003, 9(14):5142-5144.
|
[27] |
Kobayashi H, Sumimoto K, Kitanaka T, et al. Ovarian endometrioma risks factors of ovarian cancer development [J]. Eur J Obstet Gynecol Reprod Biol, 2008, 138(2):187-193.
|
[28] |
Erzen M, Raker S, Klancar B, et al. Endometriosis-associated ovarian carcinoma(EAOC): An entity distinct from other ovarian carcinomas as suggested by a nested case-control study [J]. Gynecol Oncol, 2001, 83(1):100-108.
|
[29] |
Campbell IG, Thomas EJ. Endometriosis: candidate genes [J]. Human Reproduction Update, 2001, 7(1):15-20.
|
[30] |
Birnbaum LS, Cummings AM. Dioxins and endometriosis: a plausible hypothesis [J]. Environ Health Perspect, 2002, 110(1):15-21.
|
[31] |
Sampson JA. Endometrial carcinoma of the ovary arising in endometrial tissue in that organ [J]. Arch Surg, 1925, 9(1):111-114.
|
[32] |
Pearce CL, Templeman C, Rossing MA, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies [J]. Lancet Oncol, 2012, 13(4):385-394.
|
[33] |
Slavin RE, Krum R, Dinh TV. Endometriosis-associated intestinal tumors: a clinical and pathological study of 6 cases with a review of the literature [J]. Hum Pathol, 2000, 31(4):456-463.
|
[34] |
Jones KD, Owen E, Berresford A, et al. Endometrial adenocarcinoma arising from endometriosis of the rectosigmoid colon [J]. Gynecol Oncol, 2002, 86(2):220-222.
|
[35] |
Werling RW, Yaziji H, Bacchi CE, et al.CDX2, a highly sensitive and specific marker of adenocarcinoma as of intestinal origin: an immunohistochemocal survey of 476 primary and metastatic carcinomas [J]. Am J Surg Pathol, 2003, 27(3):303-310.
|
[36] |
Miura K, Ishida K, Fujibuchi W, et al. Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database [J]. Surg Today, 2012, 42(6):515-525.
|
[37] |
Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases [J]. Mod Pathol, 2000, 13(9):962-972.
|
[38] |
Poleev A, Fickenscher H, Mundlos S, et al. PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms′ tumors [J]. Development, 1992, 116(3):611-623.
|
[39] |
Schaner ME, Ross DT, Ciaravino G, et al. Gene expression patterns in ovarian carcinomas [J]. Mol Biol Cell, 2003, 14(11):4376-4386.
|
[40] |
Modesitt SC, Tortolero-Luna G, Robinson JB, et al. Ovarian and extraovarian endometriosis-associated cancer [J]. Obstet Gynecol, 2002, 100(4):788-795.
|
[41] |
Heaps JM, Nieberg RK, Berek JS.Malignant neoplasms arising in endometriosis [J]. Obstet Gynecol, 1990, 75(6):1023-1028.
|
[42] |
Fishman A, Demirel D, Laucirica R, et al.Malignant tumors arising in endometriosis: clinical-pathological study and flow cytometry analysis [J].Obstet Gynecol, 1996, 70(1):69-74.
|
[43] |
Irvin W, Pelkey T, Rice L, et al. Andersen.Endometrial stromal sarcoma of the vulva arising in extraovarian endometriosis: a case report and literature review [J]. Gynecol Oncol, 1998, 71(2):313-316.
|
[44] |
Davis M, Rauh-Hain JA, Andrade C, et al. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary [J]. Gynecol Oncol, 2014, 132(3):760-766.
|
[45] |
Ulruch U, Richter O, Wardelmann E, et al. Endometriosis and malignoma [J]. Zentralbl Gynakol, 2003, 125(7-8):239-242.
|
[46] |
Slomovtz B, Soslow R, Chang R, et al.Serous adenocarcinoma of the inguinal region arising from endometriosis followed by a successful pregnancy [J]. Gynecol Oncol, 2002, 87(1):152-154.
|
[47] |
Judson P, Temple A, Fowler W, et al. Vaginal adenosarcoma arising from endometriosis [J]. Gynecol Oncol, 2000, 76(1):123-125.
|
[48] |
Sutton G, Blessing JA, Park R, et al. Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncologic Group [J]. Obstet Gynecol, 1996, 87(5Pt1):747-750.
|
[49] |
Erzen M, Rakar S, Klancnik B, et al. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study [J]. Gynecol Oncol, 2001, 83(1):100-108.
|
[50] |
Petersen VC, Underwood JCE, Wells M, et al. Primary endometrioid adenocarcinoma of the large intestine arising in colorectal endometriosis [J]. Histopathology, 2002, 40(2):171-176.
|